english.prescrire.org > Spotlight > Archives : 2013 > In the December issue of Prescrire International - Ceftaroline fosamil: just another intravenous antibiotic

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2013 : 1 | 30 | 60

In the December issue of Prescrire International - Ceftaroline fosamil: just another intravenous antibiotic

FREE DOWNLOAD There is no evidence that ceftaroline is more effective than tried and tested antibiotics used in patients with community-acquired pneumonia or serious skin or soft-tissue infections warranting hospitalisation. It is better to stick with established antibiotics.
Full text available for free download.

Summary

  • Ceftaroline (Zinforo°, AstraZeneca) is a new cephalosporin intended for intravenous administration (as ceftaroline fosamil). It is authorised for the treatment of community-acquired pneumonia and for serious infections of the skin and soft tissues.
     
  • In practice, there is no proof that ceftaroline represents a therapeutic advance for patients with community-acquired pneumonia warranting hospitalisation or with serious skin or soft-tissue infections. It is best to stick with better-known antibiotics.
     

Full text available for free download.

©Prescrire 1 December 2013

"Ceftaroline fosamil" Prescrire Int 2013; 22 (144): 291. (Pdf, free)
Download the full review.
Pdf, free